ClinConnect ClinConnect Logo
Search / Trial NCT01893736

Professional Breastfeeding Support Intervention

Launched by THE UNIVERSITY OF HONG KONG · Jul 2, 2013

Trial Information

Current as of July 02, 2025

Completed

Keywords

Breastfeeding Professional Support Postnatal Interventions Exclusive Breastfeeding Randomized Controlled Trial

ClinConnect Summary

The aim of this study is to determine whether early post-partum professional breastfeeding support improves breastfeeding outcomes.

The primary hypotheses are:

1. Exclusive breastfeeding rates at 1, 2, and 3 months will be increased among mother-infant pairs who receive professional lactation support or telephone follow-up support (intervention groups) when compared with those who receive usual post-natal breastfeeding support (control group);
2. The rate of any breastfeeding (predominant or partial) at 1, 2, and 3 months will be increased among mother-infant pairs in the intervention gro...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. delivers at participating trial site,
  • 2. primiparous,
  • 3. intends to breastfeed,
  • 4. 18 years of age or older,
  • 5. has singleton pregnancy,
  • 6. Cantonese speaking,
  • 7. Hong Kong resident for more than one year,
  • 8. no serious medical or obstetrical complications
  • Exclusion Criteria:
  • 1. \< 37 weeks gestation,
  • 2. an Apgar score \< 8 at five minutes,
  • 3. a birth weight \< 2500 grams,
  • 4. born with any severe medical conditions or congenital malformations,
  • 5. is placed in the special care nursery for more than 48 hours after delivery,
  • 6. is placed in the intensive care nursery after delivery,
  • 7. not entitled to health benefits in Hong Kong (NEP).

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Marie Tarrant, PhD, MPH, RN

Principal Investigator

The University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials